Thursday, July 9, 2026

pharma · Social Anxiety Disorder · Drug Drug Interaction · VTGN

Vistagen Therapeutics

Vistagen Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Cambridge, USA HQ
7 Employees
Public company Type
VTGN · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Employees
7
Programs
10
Drugs
3
Patents
6
Intelligence · Drug Pipeline

Vistagen Therapeutics pipeline

Portfolio lens on 3 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

Vistagen Therapeutics drug portfolio — 3 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

3 compounds
  1. Development asset linked to Vistagen Therapeutics in public FDA and regional records.

  2. Development asset linked to Vistagen Therapeutics in public FDA and regional records.

  3. Development asset linked to Vistagen Therapeutics in public FDA and regional records.